From: Motivations for participating in a clinical trial on an avian influenza vaccine
Main reason to participate | |||||||||
---|---|---|---|---|---|---|---|---|---|
Coverage of expenses | Collaboration with science | Protection against pandemic | Influence of other people related with the study | P -values † | |||||
(n = 15) | (n = 155) | (n = 57) | (n = 137) | ||||||
n | (%)* | n | (%)* | n | (%)* | n | (%)* | ||
Gender | 0.11 | ||||||||
Woman | 8 | (3.9) | 91 | (44.6) | 38 | (18.6) | 67 | (32.8) | a) 1.0 |
b) 1.0 | |||||||||
c) 0.79 | |||||||||
Man | 7 | (4.4) | 64 | (40.0) | 19 | (11.9) | 70 | (43.8) | d) 1.0 |
e) 0.51 | |||||||||
f) 0.16 | |||||||||
Age ‡ | |||||||||
18 to 24 | 12 | (15.0) | 29 | (36.3) | 10 | (12.5) | 29 | (36.3) | < 0.001 |
25 to 44 | 3 | (1.9) | 74 | (46.0) | 33 | (20.5) | 51 | (31.7) | a) 0.03 |
b) 0.13 | |||||||||
c) 0.01 | |||||||||
45 to 60 | 0 | (0.0) | 37 | (40.2) | 10 | (10.9) | 45 | (48.9) | d) 0.24 |
e) 0.37 | |||||||||
f) 0.10 | |||||||||
> 61 | 0 | (0.0) | 15 | (50.0) | 4 | (13.3) | 11 | (36.7) | |
Education level | 0.06 | ||||||||
Non-university | 3 | (3.2) | 34 | (35.8) | 23 | (24.2) | 35 | (36.8) | a) 1.0 |
b) 0.91 | |||||||||
c) 1.0 | |||||||||
University | 12 | (4.5) | 121 | (45.0) | 34 | (12.6) | 102 | (37.9) | d) 0.05 |
e) 1.0 | |||||||||
f) 0.29 | |||||||||
Profession ‡ | |||||||||
Health | 1 | (0.8) | 60 | (48.8) | 19 | (15.4) | 43 | (35.0) | 0.01 |
Non-health | 4 | (2.9) | 50 | (36.2) | 26 | (18.8) | 58 | (42.0) | a) 0.07 |
b) 0.27 | |||||||||
c) 0.28 | |||||||||
Inactive | 10 | (10.4) | 41 | (42.7) | 12 | (12.5) | 33 | (34.4) | d) 0.85 |
e) 0.65 | |||||||||
f) 0.87 | |||||||||
Knowledge of the study ‡ | |||||||||
Word of mouth | 8 | (3.1) | 95 | (37.3) | 36 | (14.1) | 116 | (45.5) | < 0.001 |
Talks | 1 | (2.9) | 21 | (60.0) | 6 | (17.1) | 7 | (20.0) | a) 1.0 |
b) 1.0 | |||||||||
c) 0.04 | |||||||||
Posters/pamphlets | 5 | (15.2) | 18 | (54.5) | 6 | (18.2) | 4 | (12.1) | d) 1.0 |
e) < 0.01 | |||||||||
f) < 0.01 | |||||||||
Communication media | 0 | (0.0) | 6 | (42.9) | 6 | (42.9) | 2 | (14.3) | |
Others | 0 | (0.0) | 11 | (61.1) | 3 | (16.7) | 4 | (22.2) |